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Somatic cells can be induced into pluripotent stem
cells (iPSCs) with a combination of four transcription
factors, Oct4/Sox2/Klf4/c-Myc or Oct4/Sox2/Nanog/
LIN28. This provides an enabling platform to obtain
patient-specific cells for various therapeutic and re-
search applications. However, several problems re-
main for this approach to be therapeutically relevant
due to drawbacks associated with efficiency and viral
genome integration. Recently, it was shown that neu-
ral progenitor cells (NPCs) transduced with Oct4/Klf4
can be reprogrammed into iPSCs. However, NPCs
express Sox2 endogenously, possibly facilitating
reprogramming in the absence of exogenous Sox2.
In this study, we identified a small-molecule combina-
tion, BIX-01294 and BayK8644, that enables reprog-
ramming of Oct4/Klf4-transduced mouse embryonic
fibroblasts, which do not endogenously express the
factors essential for reprogramming. This study dem-
onstrates that small molecules identified through
a phenotypic screen can compensate for viral trans-
duction of critical factors, such as Sox2, and improve
reprogramming efficiency.
INTRODUCTION
Previous studies demonstrated that stable genomic integration
and high expression of four factors, Oct4/Sox2/Klf4/c-Myc or
Oct4/Sox2/Nanog/LIN28, can reprogram fibroblast cells, B cells,
and liver and stomach epithelial cells into induced pluripotent
stem cells (iPSCs) (Hanna et al., 2008; Takahashi et al., 2007; Ta-
kahashi and Yamanaka, 2006; Yu et al., 2007). It was later shown
that iPSCs can be generated by viral integration of Oct4/Sox2/
Klf4 without c-Myc (Aoi et al., 2008; Nakagawa et al., 2008).
Such iPSCs exhibited reduced tumorigenicity in chimeras and
progeny mice (Nakagawa et al., 2008). However, in the absence
of c-Myc overexpression, the reprogramming process is much
slower, and efficiency is substantially lower. These studies also
suggested that the ectopic expression of these three transcrip-
tion factors (TFs) is required for reprogramming, since combina-568 Cell Stem Cell 3, 568–574, November 6, 2008 ª2008 Elsevier Intion of three factors excluding one of them (i.e., Oct4/Klf4/c-Myc,
Oct4/Sox2/c-Myc, or Klf4/Sox2/c-Myc) was unsuccessful to
reprogram general somatic cells into authentic iPSCs (Aoi
et al., 2008; Nakagawa et al., 2008).
Since the viral integration of these TFs is not a viable therapeu-
tic option, in this present study, we directed our efforts in finding
small molecules that could replace the presence of virally trans-
duced TFs in a quest to ultimately find a chemical cocktail that
would allow reprogramming of somatic cells in chemically
defined conditions. Recently, we and others have shown that if
the target somatic cells are chosen carefully, it is possible to
use an endogenously expressed reprogramming gene to help in
generating iPSCs (Kim et al., 2008; Shi et al., 2008). In these stud-
ies, neural progenitor cells (NPCs), which endogenously express
Sox2 (Blelloch et al., 2006), were transduced with Oct4 and Klf4
alone (OK) and were successfully reprogrammed to iPSCs. Fur-
thermore, we found that this process was greatly enhanced by
the presence of a G9a histone methyltransferase (G9a HMTase)
inhibitor, BIX-01294 (BIX) (Kubicek et al., 2007; Shi et al., 2008).
In addition, we observed that BIX could enable reprogramming
of NPCs transduced with c-Myc, Klf4, and Sox2, in the absence
of Oct4 ectopic expression. Therefore, in this particular system,
BIX seemed to compensate for the lack of Oct4 overexpression.
This present study aimed to assess if a similar strategy could
be used to find small molecules that can replace specific viral
transduction to obtain iPSCs from a general cell lineage, in which
none of the TFs deemed essential for reprogramming, Oct4,
Sox2, and Klf4, are expressed. Hence, mouse embryonic fibro-
blasts (MEFs) were used. Finding a small molecule that could
replace one of these TFs in the induction of MEF reprogramming
might lead to the identification of general pathways involved in
this process. Such chemical strategy might also be more amena-
ble for therapeutic application. Consequently, we screened a
collection of known drugs to identify small molecules that can
enable the generation of iPSCs from MEFs transduced with Oct4
and Klf4 (OK) and thus could compensate for the lack of Sox2
overexpression. Through the different screens performed, we
identified that a combination of BIX with Bayk8644 (BayK), a
L-channel calcium agonist (Schramm et al., 1983) was one of the
most effective. Bayk was of interest because it exerts its effect
upstream in cell signaling pathways and does not directly cause
epigenetic modifications. It is likely that this type of molecule can
be exploited to induce reprogramming in a more specific mannerc.
Cell Stem Cell
Compounds Enable Two-Gene iPSC Induction from MEFthan molecules acting directly at the epigenetic level causing
DNA or histone modification. Some of these epigenetic modifiers
have already been shown to facilitate the reprogramming
process, such as BIX (Shi et al., 2008), valproic acid (Huangfu
et al., 2008), and 50 azacytidine (Mikkelsen et al., 2008).
This present study demonstrates that small molecules identi-
fied through a phenotypic screen can be used to effectively
compensate for the viral transduction of a critical iPSC TF,
Sox2. Moreover, it highlights the important contribution that
small-molecule screens will eventually make to the discovery
of new molecular targets and mechanisms involved in compli-
cated biological processes such as reprogramming.
RESULTS
Phenotypic Screen Leads to the Discovery of Small
Molecules that Enable MEF Reprogramming
Transduced with Only Two TFs
Unmodified MEFs derived from E13–E14 embryos of the
129 mice were used for the initial screen. MEFs were plated on
Matrigel at 3.5 3 104 cells/well of a 6-well plate and transduced
with OK (retroviral vectors expressing Oct4 and Klf4) alone.
Within 14–21 days, treated cells were assessed for the appear-
ance of colonies that had the characteristic embryonic stem
cell (ESC) colony morphology and were positive for the pluripo-
tency marker alkaline phosphatase (ALP). Such OK-transduced
cells generated only a few small noncompact colonies, which
were weakly positive for ALP expression (Figures 1A and 1C).
These colonies initially appeared within 21 days after viral trans-
duction and were difficult to expand. Therefore, such assay sys-
tem offered a clean background for the identification of small
molecules having desirable reprogramming-inducing activity.
Using this system, compounds from a library of around 2000
known small molecules (see Experimental Procedures) were
screened and were identified as hits when they induced the
appearance of ESC colonies that were strongly positive for
ALP within 14–21 days after treatment. This image-based
method provided a more accurate assessment of reprogram-
ming as compared to homogenous reporter-based assay.
Among several primary hits that induced formation of more
than one to two compact ESC-like colonies with strong ALP
staining, we focused on the small molecule with the strongest
effect, BIX. We observed that when MEFs were treated with
BIX after OK viral transduction, compact colonies with high
levels of ALP expression could be readily detected within ap-
proximately 14–21 days (Figure 1A). These cells were also posi-
tive for Nanog, Oct4, and SSEA-1 expression (data not shown).
This result, obtained with a more general cell type, which does
not endogenously express any of the three essential reprogram-
ming genes, further validates our previous observation that BIX
has strong reprogramming-inducing activity and inhibition of
the G9a HMTase can facilitate reprogramming (Shi et al.,
2008). However, the reprogramming efficiency in MEFs trans-
duced with OK and treated with BIX was still low in comparison
to the four-factor-induced reprogramming of MEFs or the OK/
BIX NPC reprogramming. Furthermore, this small molecule
acts directly at the epigenetic level and appears to have a broad
range of action. To identify additional compounds with reprog-
ramming activity, we conducted a second screen using a similarCprotocol, but where BIX was added to the basal media after OK
viral transduction. This provided a more permissive platform to
identify new small molecules that could further improve reprog-
ramming efficiency. More importantly, this second screen could
facilitate discovery of small molecules that impact reprogram-
ming in a more specific manner, for example, by acting on signal
transduction pathways rather than on histone or DNA modifying
enzymes. In this second screen, we again assayed a library of
approximately 2000 known small molecules (see Experimental
Procedures) and found two that were able to act with BIX to
improve reprogramming, based on the criteria of the screen. One
was RG108, a DNA methyltransferase (DMNT) inhibitor (Brueck-
ner et al., 2005) that enhanced reprogramming of OK-trans-
duced MEFs in the presence of BIX (Figure 2A). However, as this
molecule, like BIX, is known to impact the cells at a general
epigenetic level, and the DNA methyltransferase inhibitor 5-aza-
cytidine has already been shown to enhance reprogramming
(Mikkelsen et al., 2008), RG108 was not pursued further for this
study. Instead, we focused our phenotypic and functional char-
acterization on another small molecule that was identified in the
Figure 1. Screening for Small Molecules Inducing iPSCs from 129
MEFs after OK Viral Transduction
(A) Example of results obtained during screen confirmations. Shown here
are photographs of 129 MEFs transduced with OK, untreated, treated with
BIX alone, and treated with BIX/BayK combination after staining for ALP
expression.
(B) Phase contrast image of 129 MEFs transduced with empty retrovirus
(negative control); no colonies were observed.
(C) Image of 129 MEFs transduced with OK without small molecules; few small
flattened colonies with weak ALP expression present.
(D) ESC-like iPSC colonies were observed 14–21 days after 129 MEFs were
transduced with OK and treated with BIX/BayK; these ESC-like colonies
exhibited strong ALP expression.
(E) iPSC colonies generated from 129 MEFs transduced with OK and treated
with BIX/BayK expressed common ESC-specific markers; panels show iPSCs
immunostained with Oct4, Nanog, Sox2, and SSEA1 antibodies. DAPI was
used as nuclear staining.ell Stem Cell 3, 568–574, November 6, 2008 ª2008 Elsevier Inc. 569
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molecule was studied further because it has no observable re-
programming activity on OK-transduced MEFs in the absence
of BIX and is not known to impact the cells directly at the epige-
netic level, but rather at the cell signal transduction level. There-
fore, BayK might play a more specific role in the reprogramming
process. When OK-transduced MEFs were treated with BIX in
combination with BayK, a significant increase in the number
and size of ALP+ colonies that closely resemble the mESC
morphology could be observed (Figures 1A and 1D) as com-
pared to OK-transduced MEFs treated with BIX alone. Further
characterization of these primary iPSC colonies showed that
they were positive for standard pluripotency markers such as
Oct4, Sox2, Nanog, and SSEA1 (Figure 1E) as determined by
immunofluorescence.
Figure 2. Generation of OK2B iPSCs from Primary OG2 MEFs
(A) Bar graph showing the average number of GFP+ colonies induced from
OG2-MEFs in three independent experiments. This graph shows data for
OG2 MEF cells transduced with four factors (Oct4, Klf4, Sox2, and cMyc;
4F); transduced with OK (OK); transduced with OK and treated with 1 mM
BIX (OK+BIX); transduced with OK and treated with 1 mM BIX + 2 mM BayK
(OK+BIX+BayK); or transduced with OK and treated with 1 mM BIX + 0.04 mM
RG108 (OK+BIX+RG108). n = 3; error bar represents standard deviation as
calculated with Excel.
(B) Fourteen to twenty-one days after OK transduction and BIX/BayK treat-
ment, GFP+ colonies were observed and are shown in a phase contrast (Ba)
and a green fluorescence (Bb) image.
(C–G) Images of OK2B iPSC colonies showing ESC marker expression:
ALP (C), Nanog (D), Oct4 (E), Sox2 (F), and SSEA1 (G). (D–G) Markers were
revealed using an Alexa Fluor 555 secondary antibody. DAPI was used as
nuclear staining.570 Cell Stem Cell 3, 568–574, November 6, 2008 ª2008 Elsevier IniPSCs Obtained from MEFs Transduced with OK
and Treated with BIX/BayK Have Pluripotency
Properties Characteristic of mESCs
To further confirm and characterize that OK transduction and
BIX/BayK treatment can induce MEFs to become iPSCs, we
used primary MEFs derived from OG2+//ROSA26+/ (OG2)
transgenic mice, which contain an Oct4-GFP reporter (Do and
Scholer, 2004). Once reprogrammed, these cells could then be
used to conveniently assess chimera and germline competency.
Similarly to 129 MEFs, OG2 MEFs transduced with OK could
generate iPSCs when treated with a combination of BayK/BIX
(OK2B iPSCs) (Figures 2A and 2B). GFP+ iPSC colonies could
be first detected on day 14–21 after viral transduction and com-
pound treatment. When OG2 MEFs were transduced with OK
and not treated with any compounds, only a few small colonies
appeared for an average of 0.5 ± 0.7 colony per 3.5 3 104 cells.
These colonies were difficult to passage and therefore were
not studied any further. Treatment of OK-transduced OG2
MEFs with BIX alone readily and reproducibly enabled reprog-
ramming as compared to OK alone, with 2.5 ± 0.7 colonies per
3.5 3 104 cells (Figure 2A). There was a further significant
improvement in the reprogramming efficiency when OG2 MEFs
transduced with OK were treated with the combination of BIX
(2 mM) and BayK (2 mM), where we observed 7.7 ± 1.5 colonies
per 3.5 3 104 cells (Figure 2A). Treatment of OK-transduced
OG2 MEFs with BayK alone, in the absence of BIX, did not
increase reprogramming efficiency above OK-transduced MEF
control (data not shown).
OK2B colonies were picked out and serially expanded on
irradiated MEF feeder cells in the conventional mESC growth
conditions in the absence of small molecules for more than
20 passages. Staining (Figures 2C–2G) and/or RT-PCR
(Figure 3A) showed that these GFP+ OK2B iPSCs express typical
pluripotency markers, including ALP, Nanog, Sox2, Oct4,
SSEA1, c-Myc, eRas, Esg1, Ecat1, and Fgf4. RT-PCR assay
also demonstrated that OK2B iPSCs expressed endogenous
Oct4 and Klf4 (Figure 3A). Bisulphite genomic sequencing
analyses of the Nanog promoter revealed that it is demethylated
in OK2B iPSCs similarly to the mESC control (R1), while the
MEFs’ Nanog promoter was hypermethylated (Figure 3B). This
result further suggests a reactivation of the stem cell transcrip-
tion program in these OK2B iPSCs. In addition, transcriptome
analysis showed that expression profile of OK2B iPSCs is greatly
similar to the one of mESCs with a Pearson correlation value of
0.96, while significantly different to MEFs’ profile with a Pearson
correlation value of 0.84 as exemplified in the clustering analysis
(see Figure S1 available online).
OK2B iPSCsDifferentiate into Cells fromAll ThreeGerm
Layers and Contribute to Germline Transmission
OK2B iPSCs could efficiently form embryoid bodies (EB) in
suspension, which could differentiate into endodermal cells (Al-
bumin and Pdx1), mesodermal cells/cardiac muscle cells (CT3),
and ectodermal cells/neurons (bIII-tubulin, Tuj1), derivatives of
the three primary germ layers (Figure 4A). In addition, OK2B
iPSCs could efficiently incorporate into the inner cell mass of
a blastocysts (Figure 4Ba) following aggregation with an eight-
cell embryo and lead to chimerism (Figure 4Bb) with germline
contribution (Figure 4Bc) in vivo after the aggregated embryosc.
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of one adult male progeny obtained from these blastocysts
(Figure 4C) with a female CD1 wild-type mouse led to the pro-
duction of LacZ+ progeny (Figure 4Da), three of which showed
Oct4-GFP+ cells (Figure 4Db), further validating that these
iPSCs could contribute to germline transmission (Figures 4B–
4D). These in vitro and in vivo characterizations confirm retroviral
transduction with only two genes, Oct4 and Klf4, and in conjunc-
tion with BIX/BayK treatment are sufficient to reprogram MEFs
into iPSCs, which are phenotypically and functionally similar to
the classic mESCs.
DISCUSSION
The studies presented here provide a further demonstration that
small molecules can be identified from rationally designed phe-
notypic screens to functionally replace viral transduction of cer-
tain TF(s), as well as improve reprogramming efficiency in gener-
ating iPSCs from a general cell type like MEFs. Such a chemical
approach for the generation of iPSCs, which offers more precise
and temporal control of the target/process, would be advanta-
geous over the genetic manipulation with oncogenes that may
also introduce harmful hard-to-detect insertional genomic alter-
ations. Similar strategies are being used to find additional small
molecules that may ultimately allow reprogramming of lineage-
restricted cells to pluripotent or multipotent state in a completely
chemically defined condition. BIX was originally identified and
characterized as a specific inhibitor for G9a HMTase (Kubicek
et al., 2007). It has been shown to reduce H3K9me2 levels at
Figure 3. OK2B iPSCs Have a Transcriptional Profile Similar to R1
mESCs
(A) RT-PCR analysis of OK2B iPSCs indicated that they express genes specific
to pluripotent mESCs. R1 mESCs were used as positive control, while OG2
MEFs were used as negative control. GAPDH was used as loading control.
(B) Bisulfite sequencing revealed that OK2B iPSCs’ nanog promoter is deme-
thylated, further suggesting a reactivation of endogenous genes specific to
mESCs. Schematic depiction of the cytosine present in the region of the
Nanog promoter that was amplified for this analysis. Open circle indicates
demethylated cytosine, while filled/black circle indicates methylated cytosine.CeG9a target genes (Feldman et al., 2006). Interestingly, histone
H3K9 methylation, mediated by G9a, and heterochromatiniza-
tion represent a highly specific mechanism for epigenetic silenc-
ing of embryonic genes such as Oct4 and Rex1 (Feldman et al.,
2006). Furthermore, it was also demonstrated that knockdown of
G9a can assist in fusion-based reprogramming of adult neuronal
cells (Ma et al., 2008). It is therefore fitting that we previously ob-
served that BIX can facilitate the generation of iPSCs from NPCs
transduced with either OK or Klf4/Sox2/c-Myc (Shi et al., 2008),
suggesting that it can compensate for the exogenous expression
of Sox2 or Oct4. However, NPCs already express significant
levels of Sox2, which might cause these cells to be more suscep-
tible to reprogramming in the conditions mentioned above. This
present study aimed at identifying small molecules that can en-
able reprogramming of MEFs, which do not express any of the
TFs deemed necessary for reprogramming. It was fortuitous
that we identified BIX in both the NPC and MEF screens, which
further confirmed that this molecule has a role in enabling and
improving the generation of iPSCs from somatic cells. Given
BIX’s characterized mechanism of action, our studies potentially
identified a molecular target whose loss of function via pharma-
cological inhibition is sufficient to compensate for the gain of
function of an essential iPSC reprogramming gene. It further
mechanistically links a specific epigenetic process, inhibition of
G9a-mediated H3K9me2, to iPSC generation. BIX may function
to facilitate shifting of the epigenetic balance from a silenced
state of pluripotency genes to an active transcription state for
cell reprogramming. On the other hand, our observation that
BayK, with a characterized activity as a specific L-type calcium
channel agonist (Schramm et al., 1983), improves reprogram-
ming efficiency is intriguing. L-type calcium channels are known
to mediate intracellular processes in different tissues, such as
blood pressure regulation, smooth-muscle contractility, insulin
secretion, cardiac development, etc. (Tosti, 2006). Furthermore,
activation of L-type calcium channels by different agonists, in-
cluding BayK, has been shown to induce intracellular signaling
through CREB activation, sarcoplasmic reticulum Ca2+ release,
and change in cAMP activity. More importantly, some reports
suggest that calcium might play a role in the control of mESC
proliferation (Heo et al., 2006). However, in our hands, treatment
of mESCs with 2 mM BayK alone or in combination with 1 mM BIX
does not lead to a change in proliferation (Figure S2). Further-
more, treatment of OG2 MEF with 2 mM BayK alone or in combi-
nation with 1 mM BIX does not induce SOX2 expression
(Figure S3). Needless to say, more work needs to be performed
to dissect the precise mechanism by which BayK impacts the re-
programming process. However, it is interesting to find that
a small molecule with activity in signaling pathways that have
not been previously linked to reprogramming can significantly
enhance its efficiency. So far, it is the first small molecule of its
type to show an effect on reprogramming, as most of the other
small molecules found up to date appear to directly modify the
epigenetic status of the cell: i.e., BIX (Shi et al., 2008), valproic
acid (Huangfu et al., 2008), and 50azacytidine (Mikkelsen et al.,
2008). Importantly, BayK seems to have several important char-
acteristics that would be ultimately desirable for a molecule to be
therapeutically relevant for in vivo reprogramming and/or regen-
eration. The fact that it does not act/reprogram on its own but
needs the presence of BIX to exert its effects suggests that cellsll Stem Cell 3, 568–574, November 6, 2008 ª2008 Elsevier Inc. 571
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iPSCs
(A) OK2B iPSCs differentiate in vitro into cells from the three germ layers:
endoderm (Albumin+ and Pdx1+), mesoderm (cardiac troponin T [CT3+]), and
ectoderm (neurons, bIII-tubulin [Tuj1+]).
(B) (Ba) iPSCs incorporates into the ICM of a blastocyst after aggregation
with an eight-cell embryo. (Bb and Bc) Chimeric embryos (13.5 dpc) were ob-
tained after transfer of the aggregated embryo into a pseudopregnant mouse
(LacZ staining and Oct4 GFP+ cells show contribution from iPSCs that are
OG2+//ROSA26+/).
(C and D) OK2B iPSCs are germline competent. (C) The surrogate mother gave
birth to a total of five pups (one female and four male). PCR on tail-tip tissues
showed that two adult males were chimeras, since their genome contained the
GFP cassette. PCR was performed because the eight-cell embryos used for
aggregation were recovered from an agouti B6C3F1 mouse and MEFs for der-
ivation of iPSCs were derived from OG2xROSA26 mice, from which F1 coat is
mostly agouti color and seldom black; iPSCs may be derived from agouti color
MEFs. These results clearly suggest that the OK2B iPSCs aggregated with the572 Cell Stem Cell 3, 568–574, November 6, 2008 ª2008 Elsevier Ithat are already undergoing a form of reprogramming, perhaps
caused by injury, might be more susceptible to its effect. This
might allow us to ultimately reprogram the target cell in a more
specific manner, without impacting healthy cells systemically,
as direct epigenetic modifiers might.
In summary, we have identified a combination of two small
molecules, BIX and BayK, that can enable MEF reprogramming
into iPSCs in conjunction with the transduction of only two TFs:
Oct4 and Klf4. This study further confirms the usefulness of a
phenotypic screening approach in identifying small molecules
that can effectively compensate for the viral transduction of a crit-
ical iPSC TF, such as Sox2. Ultimately, phenotypic small-mole-
cule screens may lead to the identification of small molecules
that will become powerful tools in providing us with new insights
into the reprogramming process and may ultimately be useful to
in vivo stem cell biology and therapy.
EXPERIMENTAL PROCEDURES
MEF Derivation
129S2/SvPasCrlf or ROSA26+//OG2+/ MEFs were derived according to the
protocol reported on the WiCell Research Institute website: ‘‘Introduction to
human embryonic stem cell culture methods’’ (http://www.wicell.org/index.
php?option=com_content&task=category&id=310&Itemid=149&sectionid=16).
Animal experiments were performed according to the Animal Protection Guide-
lines of the Max Planck Institute for Biomolecular Research, Germany.
Retrovirus Transduction and Compounds
pMX-based retroviral vectors for mouse Oct4, Klf4, c-Myc, and Sox2 were ob-
tained from Addgene (Cambridge, MA). The viral production and transduction
process was performed as described (Takahashi et al., 2007). The synthesis
and full characterization of compound BIX-01294 was as previously described
(Kubicek et al., 2007), and Bayk8644 was purchased from EMD/Calbiochem
Biochemical (San Diego, CA).
Screen for iPSC Generation from MEFs
For the primary and secondary screens, a collection of known compounds was
used. This collection was composed of roughly 2000 known bioactive mole-
cules that are commercially available, including FDA-approved drugs, known
inhibitors and activators of characterized enzymes (the LOPAC collection from
Sigma-Aldrich [St. Louis, MO]), Known Bioactive Library from BIOMOL
(Plymouth Meeting, PA), and nonoverlapping known compounds from EMD
Calbiochem (San Diego, CA).
Primary 129S2/SvPasCrlf (primary screen) or ROSA26+//OG2+/ (second-
ary screen) MEFs were plated onto Matrigel (1:50; BD Biosciences, Bedford,
MA)-coated dishes at a density of 3.5 3 104 cells per well of a 6-well plate.
Twenty-four hours later, these cells were transduced overnight with defined
retroviruses at 37C, 5% CO2. Twelve to fourteen hours later, the media on
the transduced cells were changed to mESC medium (knockout DMEM,
10% ES-qualified FBS, 10% knockout serum replacement, 1% Glutamax,
1% nonessential amino acids, penicillin/streptomycin, 0.1 mM b-mercaptoe-
thanol, 1% EmbryoMax ESC Qualified Nucleosides [Millipore, Temecula,
CA], and 103 U/ml LIF [Millipore]) (all products were from Invitrogen, Carlsbad,
CA, except where mentioned). On that same day, individual small molecules
from our known drug collection were added to the cells at a range between
0.5 and 2 mM. Compound treatment was continued for 10–14 days; the cells
were fixed and stained on day 14–21 using a standard ALP detection kit (Milli-
pore). For the second screen, 1 mM BIX was added to the mESC medium 1 day
after transduction. Five days later, in addition to 1 mM BIX, an individual small
eight-cell embryo contributed to adult chimeric mice. (Da) One male adult chi-
mera was mated with a female CD1 wild-type mouse. X-gal staining indicated
six germline transmitted F1 embryos, three of which exhibited Oct4-GFP+
germ cells, originating from OK2B iPSCs (Db). This result indicates that the
OK2B iPSCs can contribute to germline transmission.nc.
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between 0.5 and 2 mM. Mouse ESC media with defined small molecules
were refreshed every 3 days until colonies with a similar morphology to mESCs
were observed, which was usually between 14 to 21 days after transduction. In
addition to the confirmed compounds as indicated in the text, primary hits from
the second synergist screen that were not further followed up also include
PD173074, reversine, 50azacytidine, pluripotin, and dexamethasone. Further
characterization studies and repeats were carried out either on primary
129S2/SvPasCrlf or ROSA26+//OG2+/ MEFs. When ROSA26+//OG2+/
MEFs were used, the iPSC colonies could also be identified through GFP ex-
pression, as a marker of Oct4 expression. Once iPSC colonies were identified,
they were picked for expansion on MEF feeder cells in mESC medium. Some
colonies were expanded in the presence of the MEK inhibitor PD0325901 at
concentration of 0.5–2 mM to further confirm their pluripotentiality.
Immunocytochemistry and Immunofluorescence Assay
ALP staining was performed according to the manufacturer’s instructions
using the Alkaline Phosphatase Detection Kit (Millipore). For immunofluores-
cence assay, cells were fixed in 4% paraformaldehyde for 15 min at room tem-
perature (RT) and washed with PBS. They were then incubated in blocking
buffer (BB) (0.3% Triton X-100 [Sigma-Aldrich], 10% normal donkey serum
[Jackson ImmunoResearch Laboratories Inc.] in PBS [Invitrogen]) 30 min at
RT. They were then incubated with primary antibody overnight at 4C in BB.
Afterward, cells were washed with PBS and incubated with secondary anti-
body in BB for 45–60 min at RT. Primary antibodies were mouse anti-Oct4
(1:200) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), mouse anti-SSEA1
(1:200) (Santa Cruz Biotechnology Inc.), rabbit anti-Nanog (1:500) (Abcam
Inc., Cambridge, MA), mouse anti-Sox2 (1:200) (Millipore), rabbit anti-Pdx1
(1:200) (a kind gift from Dr. C. Wright), mouse anti-bIII-Tubulin (Tuj1) (1:500)
(Covance Research Products Inc., Denver, PA), mouse anti-cardiac troponin
T (CT3) (1:200) (Developmental Studies Hybridoma Bank at the University of
Iowa, Iowa City, IA), and rabbit anti-albumin (DAKO). Secondary antibodies
were Alexa Fluor 555 donkey anti-mouse or rabbit IgG (1:500) (Invitrogen).
Nuclei were detected by DAPI (Sigma-Aldrich) staining. Images were captured
using a Nikon Eclipse TE2000-U/X-cite 120 EXFO microscope with a photo-
metric CoolSnap HQ2 camera.
RT-PCR Assay
RNA was extracted from iPSCs and control cell lines using the RNeasy Plus
Mini Kit in combination with QIAshredder. The RNA was converted to cDNA
using iScript cDNA Synthesis Kit (BioRad, Hercules, CA). Amplification of
specific genes was done using primers previously published (Takahashi
et al., 2007; Takahashi and Yamanaka, 2006) and Platinum PCR SuperMix
(Invitrogen) on a Mastercycler ep gradient PCR machine (Eppendorf).
Methylation Assay
DNA from R1 cells, OG2 MEFs, and OK iPSCs (passage 10) was isolated using
the Non Organic DNA Isolation Kit (Millipore). The DNA was then treated for
bisulfite sequencing with the EZ DNA Methylation-Gold Kit (Zymo Research
Corp., Orange, CA). The treated DNA was then used to amplify sequences
of interest. Primers used for promoter fragment amplification were as previ-
ously published (Blelloch et al., 2006). The resulting fragments were cloned us-
ing the TOPO TA Cloning Kit for sequencing (Invitrogen) and sequenced.
Aggregation of iPSCs with Zona-free Embryos
iPSCs were aggregated with denuded postcompacted eight-cell stage em-
bryos to obtain aggregate chimeras. Eight-cell embryos (B6C3F1) were
flushed from females at 2.5 dpc and cultured in microdrops of KSOM medium
(10% FCS) under mineral oil. Clumps of iPSCs (10 to 20 cells) after short treat-
ment of trypsin were chosen and transferred into microdrops containing zona-
free eight-cell embryos. Eight-cell embryos aggregated with iPSCs were cul-
tured overnight at 37C, 5% CO2. Aggregated blastocysts that developed
from eight-cell stage were transferred into one uterine horn of a 2.5 dpc pseu-
dopregnant recipient. One adult male chimera was mated with a female CD1
wild-type mouse. X-gal staining showed that six F1 embryos obtained from
this natural mating of chimeric mouse and wild-type mouse were generated
by germline transmission.CeStatistical Analysis
Bar graphs and statistical analyses were performed using a standard
Student’s t test using Excel.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures
and three figures and can be found with this article online at http://www.
cellstemcell.com/supplemental/S1934-5909(08)00527-4.
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